Genes of the MAGE-A family are expressed in several types of solid tumors b
ut are silent in normal tissues with the exception of male germline cells,
which do not carry HLA molecules,Therefore, peptides encoded by MAGE-A gene
s are strictly tumor-specific antigens that can be recognized by CTL and co
nstitute promising targets for immunotherapy. The expression of 6 genes of
the MAGE-A family was tested with reverse transcriptase-polymerase chain re
action in lymphoma samples. Among 38 samples of non-Hodgkin lymphoma, 1 ana
plastic large cell lymphoma expressed genes MAGE-A1, -A2 -A3, -A4, and -A12
, and 1 lymphoepithelioid T-cell lymphoma expressed gene MAGE-A4. Five of 1
8 samples (28%) from patients with Hodgkin disease expressed gene MAGE-A4.
In tissue sections, staining by a monoclonal antibody that recognizes the M
AGE-A4 protein was observed in 11 of 53 samples (21%) from patients with Ho
dgkin disease, In the positive samples, the Reed-Sternberg cells were stron
gly stained whereas the surrounding cells were not. These results indicate
that Hodgkin disease may be a target for specific immunotherapy involving M
AGE-A4 antigens, (Blood. 2000;95:3530-3533) (C) 2000 by The American Societ
y of Hematology.